A breast cancer gene signature for indolent disease

PURPOSE: Early-stage hormone-receptor positive breast cancer is treated with endocrine therapy and the recommended duration of these treatments has increased over time. While endocrine therapy is considered less of a burden to patients compared to chemotherapy, long-term adherence may be low due to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res Treat
Hlavní autoři: Delahaye, Leonie J. M. J., Drukker, Caroline A., Dreezen, Christa, Witteveen, Anke, Chan, Bob, Snel, Mireille, Beumer, Inès J., Bernards, Rene, Audeh, M. William, van’t Veer, Laura J., Glas, Annuska M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2017
Témata:
Epidemiology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5487706/
https://ncbi.nlm.nih.gov/pubmed/28451965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4262-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky